Impact of ketogenic and low-glycemic diets on inflammatory skin conditions
Mice were subcutaneously injected with liraglutide (200 g/kg body weight) (NOVO Nordisk, Bagsvaerd, Denmark) or saline
SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma
GLP-1 receptor agonists like semaglutide and tirzepatide have gained attention for weight management, prompting questions about their role in lymphedema treatment
Whereas the levels of 1,2-benzoquinone, 11-dehydro-thromboxane B2, 12-KETE, L-malic acid, N2-succinyl-L-ornithine, ornithine, argininosuccinic acid from the fecal metabolites gradually decreased as CKD progressed, chlorohydroquinone, hydroquinone, L-cystine, fecal 12-keto-tetrahydro-leukotriene B4 (12-keto-tetrahydro-LTB4), and L-cysteine levels gradually increased Integrated network analysis based on metabolomics and metagenomics data revealed that Ruminococcus bromii , fecal hydroquinone, and serum creatinine were the major contributors to this network, therefore play major roles in CKD progression
PlexusDx Precision Peptide Genetic Test analyzes 14 metabolic and neuropsychiatric pathways across 49 peptides, including genetic variants in GLP1R (rs6923761), GIPR (rs1800437), and other loci that influence how your brain and body respond to GLP-1 therapy
